AlterDiag
AlterDiag is a French diagnostics startup (founded 2024) focused on research, development and commercialization of rapid diagnostic tests for infectious diseases. The company develops lateral flow immunochromatographic tests and programs to integrate single-domain antibodies (VHH/nanobodies) into point-of-care assays, performs analytical evaluation of third-party lateral flow tests, and manages industrialization, regulatory registration and distribution partnerships.
Industries
Nr. of Employees
small (1-50)
Products
VHH-based lateral flow rapid tests (in development)
R&D programs to develop lateral flow rapid diagnostic tests that incorporate single-domain antibodies (VHH/nanobodies) for improved targeting and stability; plans for industrialization and regulatory submission.
VHH-based lateral flow rapid tests (in development)
R&D programs to develop lateral flow rapid diagnostic tests that incorporate single-domain antibodies (VHH/nanobodies) for improved targeting and stability; plans for industrialization and regulatory submission.
Services
Assay research & development
End-to-end R&D for lateral flow immunochromatographic tests, including prototype design and integration of single-domain antibodies.
Analytical evaluation and quality assessment
Technical evaluation of sensitivity, specificity and overall performance for in-house or third-party rapid tests.
Industrialization and regulatory support
Support for industrialization (scale-up) and preparation of regulatory registrations and compliance for IVD commercialization.
Commercial distribution and partnership management
Establishing distribution agreements and managing commercial partnerships for global distribution of rapid diagnostic tests.
Assay research & development
End-to-end R&D for lateral flow immunochromatographic tests, including prototype design and integration of single-domain antibodies.
Analytical evaluation and quality assessment
Technical evaluation of sensitivity, specificity and overall performance for in-house or third-party rapid tests.
Industrialization and regulatory support
Support for industrialization (scale-up) and preparation of regulatory registrations and compliance for IVD commercialization.
Commercial distribution and partnership management
Establishing distribution agreements and managing commercial partnerships for global distribution of rapid diagnostic tests.
Expertise Areas
- Rapid diagnostic test (RDT) development
- Lateral flow immunoassay (LFIA) design
- Single-domain antibody (VHH/nanobody) assay integration
- Assay validation and analytical performance
Key Technologies
- Lateral flow immunoassays (LFT/LFIA)
- Immunochromatography
- Single-domain antibodies (VHH / nanobodies)
- Nanotechnology for diagnostics